Rep. Burgess Vows To Fight FDA Panel Conflict-Of-Interest Restrictions

Relaxing conflict-of-interest restrictions for FDA advisory panels will be a top priority for Texas Republican Congressman Michael Burgess during the upcoming reauthorization of device and drug user fee programs, he said Sept. 26.